Seoul, South Korea

Yong W Lee

This inventor holds 2 USPTO granted patents. Top assignees: Cheil Foods & Chemicals, Inc., Korea Institute of Science and Technology. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong W Lee. Retrieved from https://idiyas.com/inventor/yong-w-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yong W Lee: Innovator in Antibiotic Development

Introduction

Yong W Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of antibiotic development, particularly focusing on Legionella-specific antibiotics. With a total of 2 patents, his work has the potential to impact public health positively.

Latest Patents

Yong W Lee's latest patents include a Legionella-specific antibiotic produced by the microorganism Streptomyces sp. AL91 KCCM 10055. The antibiotic, designated as AL072, is disclosed in his patents, showcasing its unique formula. This innovative antibiotic aims to target Legionella bacteria effectively, which can cause severe pneumonia.

Career Highlights

Throughout his career, Yong W Lee has worked with esteemed organizations such as the Korea Institute of Science and Technology and Cheil Foods & Chemicals, Inc. His experience in these institutions has allowed him to develop and refine his expertise in antibiotic research and development.

Collaborations

Yong W Lee has collaborated with notable colleagues, including Chul Hwan Lee and Yoong H Lim. These partnerships have contributed to the advancement of his research and the successful development of his patented antibiotics.

Conclusion

Yong W Lee's innovative work in antibiotic development, particularly his focus on Legionella-specific treatments, highlights his significant contributions to the field. His patents and collaborations reflect a commitment to advancing medical science and improving public health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…